Breaking News Instant updates and real-time market news.

OUT

Outfront Media

$24.51

0.41 (1.70%)

11:06
09/28/17
09/28
11:06
09/28/17
11:06

Outfront Media price target raised to $28 at Loop Capital

Loop Capital analyst David Miller raised his price target on Outfront Media to $28 from $27 and maintained his Buy rating after the company held a conference call going over its new NYC Mass Transit contract, where Outfront Media "will not only continue as the sole vendor, but will do so at measurably better economics" for the NYC subway, rails, and buses for a ten-year term. Miller calls the contract an "overhang fully lifted" that leaves no reason not to buy the stock.

  • 02

    Oct

OUT Outfront Media
$24.51

0.41 (1.70%)

05/04/17
LOOP
05/04/17
NO CHANGE
Target $25
LOOP
Hold
OUTFRONT Media valuation gap to Lamar warranted, says Loop Capital
Loop Capital analyst David Miller noted that OUTFRONT Media (OUT) reported Q1 revenues that missed expectations due to systemic weakness in its National book and pulled its annual AFFO guidance, also pointing to its National book as reason for the sluggishness. While OUTFRONT and Lamar Advertising (LAMR) are comps, they are also "very different" and the gap in valuation between the two is warranted, said Miller, who points to Lamar's pricing power, lead in digital and lack of exposure to the lower-margin Transportation category as reasons for its premium. Miller keeps a $25 price target and Hold rating on OUTFRONT shares.
06/05/17
LOOP
06/05/17
UPGRADE
Target $27
LOOP
Buy
Outfront Media upgraded to Buy from Hold at Loop Capital
Loop Capital analyst David Miller upgraded Outfront Media to Buy and raised his price target for the shares to $27 from $25. The analyst believes the "reward outweighs the risk" with the shares down 17% over the past 15 weeks. The current 6.3% dividend yield is "compelling by any measure," Miller tells investors in a research note. He believes a dividend cut is unlikely.
06/05/17
06/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Yelp (YELP) upgraded to Buy from Neutral at BofA/Merrill with analyst Justin Post saying consensus estimates are achievable following the first quarter headline miss. The analyst sees improved quarterly net account adds ahead and improved execution driving shares higher. 2. Exxon Mobil (XOM) upgraded to Outperform from Sector Perform at Scotia Howard Weil with the firm saying recent weakness provides a buying opportunity for this defensive play within the oil patch. 3. eBay (EBAY) upgraded to Outperform from Neutral at Credit Suisse with analyst Paul Bieber assuming coverage on the stock while saying there are multiple paths to create value. 4. Gap (GPS) upgraded to Outperform from Perform at Oppenheimer with analyst Anna Andreeva saying the shares are down 17% from last month's highs despite the retailer posting 12% earnings growth in the first quarter. 5. Outfront Media (OUT) upgraded to Buy from Hold at Loop Capital with analyst David Miller saying he believes the "reward outweighs the risk" with the shares down 17% over the past 15 weeks. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/17
LOOP
07/13/17
NO CHANGE
LOOP
Buy
Outfront may benefit from strong TV ad market 'spillover,' says Loop Capital
Loop Capital analyst David Miller said his contacts within the media buying community are discussing a "spillover effect" from the much better than expected TV upfronts that is causing certain advertisers to be priced out of television and move to out-of-home instead. The greatest beneficiary could be Outfront Media (OUT), because much of its revenues come from national advertisers, compared to competitor Lamar Advertising (LAMR), which is more locally focused, Miller tells investors. He keeps Buy ratings on both Outfront and Lamar.

TODAY'S FREE FLY STORIES

07:56
02/22/18
02/22
07:56
02/22/18
07:56
Conference/Events
The FTC to hold a meeting »

Open Commission Meeting…

HASI

Hannon Armstrong

$20.77

-0.22 (-1.05%)

07:55
02/22/18
02/22
07:55
02/22/18
07:55
Recommendations
Hannon Armstrong analyst commentary  »

Hannon Armstrong weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$125.67

-0.35 (-0.28%)

07:55
02/22/18
02/22
07:55
02/22/18
07:55
Recommendations
Workday analyst commentary  »

Workday price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

NFX

Newfield Exploration

$23.20

-2.53 (-9.83%)

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Upgrade
Newfield Exploration rating change  »

Newfield Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CNP

CenterPoint Energy

$26.23

-0.5 (-1.87%)

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Hot Stocks
CenterPoint targets FY18 Energy Services operating income $55M-$65M »

Says capital rate base…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 19

    Mar

  • 06

    Apr

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Conference/Events
CFA Society of Milwaukee to hold a luncheon discussion »

Bill Stone, CMT of PNC…

07:53
02/22/18
02/22
07:53
02/22/18
07:53
Conference/Events
STAT Plus to hold webinar »

STAT Senior Science…

AAOI

Applied Optoelectronics

$34.55

1.22 (3.66%)

07:51
02/22/18
02/22
07:51
02/22/18
07:51
Recommendations
Applied Optoelectronics analyst commentary  »

Applied Optoelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 29

    Mar

07:51
02/22/18
02/22
07:51
02/22/18
07:51
General news
Futures pointing to higher open »

Stock futures have…

07:51
02/22/18
02/22
07:51
02/22/18
07:51
Conference/Events
The FCC to hold a commission meeting »

Open Commission Meeting…

07:50
02/22/18
02/22
07:50
02/22/18
07:50
Conference/Events
Federal Reserve Bank of New York President speaks at press briefing »

New York Federal Reserve…

STMP

Stamps.com

$184.95

-5.1 (-2.68%)

07:49
02/22/18
02/22
07:49
02/22/18
07:49
Recommendations
Stamps.com analyst commentary  »

Stamps.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 23

    May

LNKD

Acquired by MSFT

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Conference/Events
Detroit Economic Club to hold a breakfast meeting »

Brenda Meller, Owner and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MCS

Marcus

$26.10

1 (3.98%)

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Earnings
Marcus reports Q4 EPS $1.21, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    May

PHX

Panhandle Oil & Gas

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Initiation
Panhandle Oil & Gas initiated  »

Panhandle Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 11

    Mar

CRM

Salesforce

$114.48

0.13 (0.11%)

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 28

    Feb

07:46
02/22/18
02/22
07:46
02/22/18
07:46
Conference/Events
FDA to co-host a workshop »

The FDA, American…

MLNX

Mellanox

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Recommendations
Mellanox analyst commentary  »

Mellanox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

RDHL

RedHill Biopharma

$6.26

0.05 (0.81%)

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Earnings
RedHill Biopharma reports Q4 EPS (26c), consensus (60c) »

Reports Q4 revenue $2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

07:43
02/22/18
02/22
07:43
02/22/18
07:43
Conference/Events
JPMorgan to hold a conference »

Korea Conference will be…

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Conference/Events
Deutsche Bank to hold a conference »

Indonesia Corporate Days…

ROKU

Roku

$51.10

-0.08 (-0.16%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 21

    Mar

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees Q1 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

AKBA

Akebia

$14.31

0.69 (5.07%)

, CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

07:41
02/22/18
02/22
07:41
02/22/18
07:41
Conference/Events
RBC Capital to hold a conference »

Global Healthcare…

AKBA

Akebia

$14.31

0.69 (5.07%)

CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

RDUS

Radius Health

$37.71

-0.51 (-1.33%)

TYME

Tyme Technologies

$3.37

-0.06 (-1.75%)

HCA

HCA Healthcare

$100.35

-0.65 (-0.64%)

ARAY

Accuray

MDRX

Allscripts

$13.57

0.335 (2.53%)

ABEO

Abeona Therapeutics

$11.70

0.1 (0.86%)

SGEN

Seattle Genetics

$54.11

-0.05 (-0.09%)

INSY

Insys Therapeutics

$7.93

0.34 (4.48%)

SPPI

Spectrum

$20.51

0.21 (1.03%)

SPH

Suburban Propane

$24.10

-0.2 (-0.82%)

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

DEPO

Depomed

$7.46

0.07 (0.95%)

KTWO

K2M Group

$19.09

-0.01 (-0.05%)

INOV

Inovalon

$11.68

-1.025 (-8.07%)

IMMU

Immunomedics

$16.38

0.16 (0.99%)

OVID

Ovid Therapeutics

$6.83

-0.2 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 11

    Mar

  • 14

    Mar

  • 01

    May

  • 03

    May

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.